Page 61 - Read Online

Han et al. Cancer Drug Resist 2024;7:16 https://dx.doi.org/10.20517/cdr.2024.01 Page 23 of 25

Completed the GO and KEGG enrichment analysis and revised the manuscript: An J
Conducted the experimental verification: Li S, Fan H, Wang L
Contributed to the animal experiment: Du Q
Assisted in conceptualization: Du J
Supervised and revised the manuscript: Yang Y, Song Y
Administrated funding and revised the manuscript: Peng F
This manuscript was conceptualized by all the authors.
All authors have read and agreed to the published version of the manuscript.

Availability of data and materials
The following supporting information can be downloaded.

Financial support and sponsorship
The study was supported by National Natural Science Foundation of China (No. 82003879), Project of
Science and Technology Department of Sichuan Province (No. 2023NSFSC1928; 2023NSFSC1992), Young
Elite Scientists Sponsorship Program by China Association for Science and Technology (No. CACM-2020-
QNRC1-01), and the Fundamental Research Funds for the central Universities.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
All animal experiments followed the regulations of ethics committee of the Experimental Animal
Administration of Sichuan University (NO. K2024006).

Consent for publication
Not applicable.

Copyright
© The Author(s) 2024.

REFERENCES
1. Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN. World Health Organization 2021 classification of central nervous system
tumors and implications for therapy for adult-type gliomas: a review. JAMA Oncol 2022;8:1493-501. DOI PubMed
2. Wang L, Li S, Fan H, et al. Bifidobacterium lactis combined with Lactobacillus plantarum inhibit glioma growth in mice through
modulating PI3K/AKT pathway and gut microbiota. Front Microbiol 2022;13:986837. DOI PubMed PMC
3. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro
Oncol 2021;23:1231-51. DOI PubMed PMC
4. Cai X, Wang M, Mu P, et al. Sequence-defined nanotubes assembled from IR780-conjugated peptoids for chemophototherapy of
malignant glioma. Research 2021;2021:9861384. DOI PubMed PMC
5. Xu S, Tang L, Li X, Fan F, Liu Z. Immunotherapy for glioma: current management and future application. Cancer Lett 2020;476:1-12.
DOI
6. Stupp R, Mason WP, van den Bent MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and
Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. Oncol Times 2005;27:15-6. DOI
7. Han M, Li S, Fan H, An J, Peng C, Peng F. Regulated cell death in glioma: promising targets for natural small-molecule compounds.
Front Oncol 2024;14:1273841. DOI PubMed PMC
8. Tamtaji OR, Razavi ZS, Razzaghi N, Aschner M, Barati E, Mirzaei H. Quercetin and glioma: which signaling pathways are involved?
Curr Mol Pharmacol 2022;15:962-8. DOI PubMed
9. Liu A, Jiang B, Song C, et al. Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR-1236/HER2
signaling pathway. MedComm 2023;4:e282. DOI PubMed PMC